Ketamine suppresses endotoxin-induced NF-kappaB activation and cytokines production in the intestine.
J Sun, X D Wang, H Liu...
https://pubmed.ncbi.nlm.nih.gov/14982564/Actively Recruiting
Led by Nanjing First Hospital, Nanjing Medical University · Updated on 2025-02-10
184
Participants Needed
1
Research Sites
17 weeks
Total Duration
Researchers are investigating whether low doses of esketamine can improve sleep quality in patients undergoing modified radical mastectomy for breast cancer after chemotherapy. This study focuses on managing postoperative sleep disturbances, which are common and can negatively affect recovery. The trial involves 184 female participants aged 18 to 65 who have breast cancer and are receiving neoadjuvant chemotherapy. Sleep disturbances after surgery can affect pain, inflammation, and overall recovery, and this study aims to explore whether esketamine can help reduce these problems. Participants will be randomly assigned to one of two groups. One group will receive a continuous infusion of esketamine 0.3 mgkgh during their surgery after anesthesia induction, while the other group will receive a placebo infusion of normal saline. The infusion continues until the end of the operation. The study includes assessments before surgery, on the day after surgery, and three days after surgery to evaluate sleep quality, pain, anxiety, depression, and blood markers related to inflammation and brain function. Participants will complete several rating scales such as the Athens Insomnia Scale, Visual Analog Pain Rating Scale, and the Hospital Anxiety and Depression Scale at multiple time points. Blood samples will be collected to measure inflammatory and other biological markers. Researchers will monitor analgesic use and follow up on sleep disturbances three days after surgery. The main outcome measured is the incidence of postoperative sleep disturbance on the first day after surgery. Additional assessments will occur on other days to track pain, mood, and biological changes. The study will last from admission to three days post-surgery.
CONDITIONS
Effect of Subanesthetic Dose of Esketamine on Sleep Quality
W
wenwen zhang, Dr
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nanjing First Hospital, Nanjing Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants undergo modified radical mastectomy for breast cancer. After induction of general anesthesia, participants receive a continuous infusion of either low-dose esketamine or normal saline until the end of the operation.
1 surgical visit (in-person)
Duration - 7 days after surgery
Participants are monitored for postoperative sleep disturbances and recovery. Assessments include sleep quality, pain scores, anxiety and depression levels, and inflammatory markers on days following surgery.
Multiple visits on postoperative days 1, 2, 3, 5, and 7 (in-person)
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
J Sun, X D Wang, H Liu...
https://pubmed.ncbi.nlm.nih.gov/14982564/Bijia Song, Jun-Chao Zhu
https://pubmed.ncbi.nlm.nih.gov/34970147/James W Murrough, Dan V Iosifescu, Lee C Chang...
https://pubmed.ncbi.nlm.nih.gov/23982301/Man Luo, Bijia Song, Junchao Zhu
https://pubmed.ncbi.nlm.nih.gov/32733363/Anees Bahji, Gustavo H Vazquez, Carlos A Zarate
https://pubmed.ncbi.nlm.nih.gov/33022440/Bijia Song, Junchao Zhu
https://pubmed.ncbi.nlm.nih.gov/34992482/Di Qiu, Xing-Ming Wang, Jin-Jin Yang...
https://pubmed.ncbi.nlm.nih.gov/36454569/Mingqia Wang, Bin Zhang, Yangling Zhou...
https://pubmed.ncbi.nlm.nih.gov/33387333/S Kohtala, O Alitalo, M Rosenholm...
https://pubmed.ncbi.nlm.nih.gov/33189715/Ellyn E Matthews, Ann M Berger, Sarah J Schmiege...
https://pubmed.ncbi.nlm.nih.gov/24650832/Nanjing First Hospital, Nanjing Medical University
Lead Sponsor